Trial Profile
First Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors, a Phase II Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 02 Oct 2005 New trial record.